Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
Clinical and Translational Medicine · 2024-11 · 14 (11)
DOI: 10.1002/ctm2.70070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 25.10.2024. Verfasst von Yipeng He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China. Hauptthemen laut MEDLINE: Neoplasms, Protein Processing, Post-Translational. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lactylation, a recently identified form of protein post‐translational modification (PTM), has emerged as a key player in cancer biology. The Warburg effect, a hallmark of tumour metabolism, underscores the significance of lactylation in cancer progression. By regulating gene transcription and protein function, lactylation facilitates metabolic reprogramming, enabling tumours to adapt to nutrient limitations and sustain rapid growth. Over the past decade, extensive research has revealed the intricate regulatory network underlying lactylation in tumours. Large‐scale sequencing and machine learning have confirmed the widespread occurrence of lactylation sites across the tumour proteome. Targeting lactylation enzymes or metabolic pathways has demonstrated promising anti‐tumour effects, highlighting the therapeutic potential of this modification. This review comprehensively explores the mechanisms of lactylation in cancer cells and the tumour microenvironment. We expound on the application of advanced omics technologies for target identification and data modelling within the lactylation field. Additionally, we summarise existing anti‐lactylation drugs and discuss their clinical implications. By providing a comprehensive overview of recent advancements, this review aims to stimulate innovative research and accelerate the translation of lactylation‐based therapies into clinical practice. Key points Lactylation significantly influences tumour metabolism and gene regulation, contributing to cancer progression. Advanced sequencing and machine learning reveal widespread lactylation sites in tumours. Targeting lactylation enzymes shows promise in enhancing anti‐tumour drug efficacy and overcoming chemotherapy resistance. This review outlines the clinical implications and future research directions of lactylation in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
ORCID-Profile: Fan Cheng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, Y., Song, T., Ning, J., Wang, Z., Yin, Z., Jiang, P., Yuan, Q., Yu, W., & Cheng, F. (2024). Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials. Clinical and Translational Medicine, 14(11). https://doi.org/10.1002/ctm2.70070
Vancouver
He Y, Song T, Ning J, Wang Z, Yin Z, Jiang P, et al. Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials. Clinical and Translational Medicine. 2024;14(11). doi:10.1002/ctm2.70070
BibTeX
@article{He2024,
author = {He, Yipeng and Song, Tianbao and Ning, Jinzhuo and Wang, Zefeng and Yin, Zhen and Jiang, Pengcheng and Yuan, Qin and Yu, Weimin and Cheng, Fan},
title = {Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {11},
doi = {10.1002/ctm2.70070}
}
EUVIMED